Salivary gland carcinomas (SGC) account for less than 5% of head and neck malignant
neoplasms, further subcategorized in over 20 histological subtypes. For the most part …

Abstract Objective Mucoepidermoid Carcinoma (MEC) is the most common malignant
salivary gland neoplasm, representing 10 to 15% of all salivary neoplasms. A review of the …

PURPOSE To provide evidence-based recommendations for practicing physicians and
other healthcare providers on the management of salivary gland malignancy. METHODS …

Purpose: In locally advanced p16+ oropharyngeal squamous cell carcinoma (OPSCC),(i) to
investigate kinetics of human papillomavirus (HPV) circulating tumor DNA (ctDNA) and …

Salivary gland neoplasms are an uncommon and widely heterogeneous group of tumors. In
recent years, there has been considerable progress in efforts to reveal the molecular …

Mucoepidermoid carcinoma (MEC) is the most common salivary gland malignancy, but
categorization is complicated by variability in grading systems and uncertain prognostic …

Mucoepidermoid carcinoma (MEC) is the most common salivary gland malignancy. Recent
studies have shown that most MECs harbor gene fusions involving MAML2—an alteration …

No effective systemic treatment is available for patients with unresectable, recurrent, or
metastatic mucoepidermoid carcinoma (MEC), the most common salivary gland malignancy …

Salivary gland cancers (SGCs), categorized as head and neck cancers (HNCs), constitute
about 6% of head and neck cancer diagnoses based on estimate by American Head and …

Introduction: Salivary gland carcinomas (SGC) are histologically diverse cancers and next-
generation sequencing (NGS) to identify key molecular targets is an important aspect in the …